Enzyme combinations to reduce brain tissue swelling
AssigneeThe Trustees of Columbia University in the City of New York
InventorsBenjamin Simon Elkin, Barclay Morrison, III, John Desmond Finan
Life of this patent
Estimating the term…
Abstract
Tissue fixed charge density (FCD) is identified as another potential therapeutic target for reducing brain tissue swelling. Reduction of the FCD could reduce the thermodynamic force driving water entry into the brain. The present invention discloses chondroitinase ABC (ChABC) reduces tissue FCD and reduces tissue swelling, indicating that it may be an effective treatment to reduce edema and control intracranial pressure.
Claims5
A method of reducing brain tissue swelling in a subject in need thereof, comprising the step of administering to the subject a composition comprising an enzyme that digests chondroitin sulfate proteoglycans, an enzyme that digests heparin sulfate proteoglycans, and an enzyme that digests DNA.
Dependencies are inferred from the claim text.